VWF and Thrombocytosis: Tefferi et Barbui therefore recommended to measure von Willebrand factor (vWF) antigen and a parameter reflecting vWF function (i.e., vWF or ristocetin cofactor activity) in patients with either extreme thrombocytosis or abnormal bleeding irrespective of platelet counts [11].